PARIS (Reuters) -French unions have called on workers at Sanofi to strike from Thursday to protest a planned sale of the ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. France is taking a small stake in Sanofi’s consumer healthcare business in order to quell a political ...

(Bloomberg) -- After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its over-the-counter business to a US buyout firm descended into ...

France’s industry minister has said that the option of blocking a €15.5bn deal to sell Sanofi’s consumer pharmaceuticals division to US private equity fund Clayton, Dubilier & Rice is “abs ...

Sanofi said it is the third-largest business worldwide in the market for over-the-counter medicines, vitamins and supplements. CD&R -- which has a battery of investments in France -- would help ...

The breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the country following the talks between Sanofi, CD&R and the government ...

with Sanofi last week confirming it was in talks with CD&R. The possibility of a deal with the US firm has, however, caused uproar in France. Opella is best known for its branded paracetamol ...

France’s government has hinted at the possibility of blocking the sale of Sanofi’s consumer pharmaceuticals division to CD&R, citing concerns over employment and national healthcare interests.

The French government will need guarantees that production of Doliprane will stay in France to allow the sale of the Sanofi's consumer health branch to go ahead, economy minister Antoine Armand ...